Zimmer Biomet reports fourth-quarter, full-year 2018 financial results

Zimmer Biomet reported its fourth-quarter 2018 net sales of approximately $2 billion dollars, representing a 0.1% increase over the prior year period. Full-year 2018 net sales were $7.9 billion, resulting in a 1.7% increase over the prior year, according to a company press release.

Bryan Hanson, the company’s CEO and president, said the financial results were in-line with overall expectations. The company is looking to deliver several new products and platform technologies.

According to the release, net loss in the fourth quarter was $901.1 million, which included goodwill impairment and litigation charges. Net earnings on an adjusted basis were $447.9 million. Within the quarter, Zimmer Biomet paid $49 million in dividends and declared a fourth-quarter dividend of $0.24 per share.

Reference: